S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
3 lithium stocks to ride a multi-year cycle
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Goldman upgraded Nvidia stock, one metric says it could go higher
Autozone stock price is still in the rally zone
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Closing prices for crude oil, gold and other commodities
New highs are coming for Lowe’s stock despite mixed results
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Consumer confidence slips in February as anxiety over potential recession surprisingly reappears
Thinking long-term? Don't lose interest in Pinterest
S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
3 lithium stocks to ride a multi-year cycle
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Goldman upgraded Nvidia stock, one metric says it could go higher
Autozone stock price is still in the rally zone
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Closing prices for crude oil, gold and other commodities
New highs are coming for Lowe’s stock despite mixed results
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Consumer confidence slips in February as anxiety over potential recession surprisingly reappears
Thinking long-term? Don't lose interest in Pinterest
S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
3 lithium stocks to ride a multi-year cycle
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Goldman upgraded Nvidia stock, one metric says it could go higher
Autozone stock price is still in the rally zone
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Closing prices for crude oil, gold and other commodities
New highs are coming for Lowe’s stock despite mixed results
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Consumer confidence slips in February as anxiety over potential recession surprisingly reappears
Thinking long-term? Don't lose interest in Pinterest
S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
3 lithium stocks to ride a multi-year cycle
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Goldman upgraded Nvidia stock, one metric says it could go higher
Autozone stock price is still in the rally zone
Hunting for Domestic Vanadium - The U.S. Govt. Did WHAT? (Ad)
Closing prices for crude oil, gold and other commodities
New highs are coming for Lowe’s stock despite mixed results
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Consumer confidence slips in February as anxiety over potential recession surprisingly reappears
Thinking long-term? Don't lose interest in Pinterest

Rallybio (RLYB) News Today

$2.12
+0.32 (+17.78%)
(As of 02/27/2024 ET)
SourceHeadline
businesswire.com logoRallybio to Present at the TD Cowen 44th Annual Health Care Conference
businesswire.com - February 26 at 8:00 AM
marketbeat.com logoFY2023 Earnings Estimate for Rallybio Co. Issued By HC Wainwright (NASDAQ:RLYB)
marketbeat.com - February 9 at 6:27 AM
marketbeat.com logoFY2028 Earnings Estimate for Rallybio Co. Issued By Wedbush (NASDAQ:RLYB)
marketbeat.com - February 8 at 8:54 AM
msn.com logoJefferies cuts Rallybio to hold, cites lack of near-term catalysts
msn.com - February 7 at 5:07 PM
msn.com logoRallybio Announces Workforce Reduction and Restructuring Costs
msn.com - February 7 at 12:06 PM
marketbeat.com logoRallybio (NASDAQ:RLYB) Price Target Cut to $8.00
marketbeat.com - February 7 at 11:35 AM
markets.businessinsider.com logoRallybio’s Strategic Focus and Strengthened Fiscal Position Garner Buy Rating
markets.businessinsider.com - February 7 at 7:06 AM
markets.businessinsider.com logoRallybio Announces Portfolio Prioritization Plan; To Reduce Workforce By 45%
markets.businessinsider.com - February 6 at 3:31 PM
msn.com logoMadrigal Pharmaceuticals, Cerus among healthcare movers
msn.com - February 6 at 10:30 AM
marketwatch.com logoRallybio to Cut 45% of Staff in Portfolio Prioritization
marketwatch.com - February 6 at 10:30 AM
msn.com logoRallybio shares jump 13% on restructuring, cash runway extension
msn.com - February 6 at 10:30 AM
finance.yahoo.com logoRallybio Announces Portfolio Prioritization and Provides Corporate Update
finance.yahoo.com - February 6 at 10:30 AM
msn.com logoCanada's economy likely grew in December, avoiding recession
msn.com - February 2 at 10:34 PM
markets.businessinsider.com logoRallybio’s Drug Pipeline Promises Breakthroughs in FNAIT and gMG Treatments: Kapoor Maintains Buy Rating
markets.businessinsider.com - January 6 at 2:19 AM
finance.yahoo.com logoRallybio Highlights Portfolio Advances and Outlines Expected Milestones in 2024
finance.yahoo.com - January 4 at 12:38 PM
markets.businessinsider.com logoBuy Rating Affirmed for Rallybio on Strong Phase 1b Results and Strategic Focus
markets.businessinsider.com - December 21 at 1:12 PM
finance.yahoo.com logoRallybio Announces Preliminary Phase 1 Multiple Ascending Dose Data for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5
finance.yahoo.com - December 20 at 9:33 AM
businesswire.com logoRallybio Presents Natural History Study for Fetal and Neonatal Alloimmune Thrombocytopenia at the 65 th American Society of Hematology Annual Meeting
businesswire.com - December 10 at 3:46 PM
finance.yahoo.com logoRallybio Presents Natural History Study for Fetal and Neonatal Alloimmune Thrombocytopenia at the 65th American Society of Hematology Annual Meeting
finance.yahoo.com - December 9 at 12:39 PM
markets.businessinsider.com logoBuy Rating Affirmed for Rallybio as RLYB212 Shows Promise in FNAIT Treatment Advancements
markets.businessinsider.com - November 29 at 5:21 AM
msn.com logoRallybio posts early Phase 1 data for lead candidate in bleeding disorder
msn.com - November 28 at 5:43 PM
finance.yahoo.com logoRallybio Announces Preliminary Multiple Dose Data from the Completed Phase 1 Safety and Pharmacokinetics Study for RLYB212, an Anti-HPA-1a Monoclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia
finance.yahoo.com - November 28 at 7:43 AM
morningstar.com logoRallybio Corp RLYB
morningstar.com - November 25 at 2:27 PM
markets.businessinsider.com logoExpert Ratings for Rallybio
markets.businessinsider.com - November 10 at 1:03 PM
markets.businessinsider.com logoPromising Pipeline and Strong Financial Performance: Rallybio Earns ‘Buy’ Rating
markets.businessinsider.com - November 10 at 8:02 AM
msn.com logoRallybio GAAP EPS of -$0.45
msn.com - November 9 at 3:44 PM
benzinga.com logoRallybio: Q3 Earnings Insights
benzinga.com - November 9 at 10:44 AM
finance.yahoo.com logoRallybio Reports Third Quarter 2023 Financial Results and Provides Business Updates
finance.yahoo.com - November 9 at 10:44 AM
finance.yahoo.com logoRallybio Announces Acceptance of FNAIT Natural History Study Abstract for Presentation at the 65th American Society of Hematology Annual Meeting
finance.yahoo.com - November 2 at 11:36 AM
finance.yahoo.com logoRallybio to Present at the JonesTrading 2023 Healthcare Summit
finance.yahoo.com - October 3 at 1:13 PM
msn.com logoRallybio: Gearing Up To Be An Opportunity
msn.com - September 15 at 7:47 PM
markets.businessinsider.com logoWhere Rallybio Stands With Analysts
markets.businessinsider.com - September 5 at 4:31 PM
markets.businessinsider.com logoJMP Securities Sticks to Its Buy Rating for Rallybio (RLYB)
markets.businessinsider.com - September 5 at 3:15 AM
msn.com logoRallybio reports results from trial of C5 inhibitor RLYB116
msn.com - September 4 at 8:34 AM
finance.yahoo.com logoRallybio to Present at Upcoming Investor Conferences in September
finance.yahoo.com - August 31 at 7:31 PM
finance.yahoo.com logoIs Rallybio (NASDAQ:RLYB) In A Good Position To Deliver On Growth Plans?
finance.yahoo.com - August 22 at 3:54 PM
marketbeat.com logoResearch Analysts Set Expectations for Rallybio Co.'s Q3 2023 Earnings (NASDAQ:RLYB)
marketbeat.com - August 11 at 8:42 AM
msn.com logoJP Morgan Maintains Rallybio (RLYB) Overweight Recommendation
msn.com - August 11 at 3:10 AM
finance.yahoo.com logoRallybio Reports Second Quarter 2023 Financial Results and Provides Business Updates
finance.yahoo.com - August 8 at 10:47 AM
finance.yahoo.com logoRallybio to Present at the 2023 Wedbush PacGrow Healthcare Conference
finance.yahoo.com - August 2 at 8:40 AM
msn.com logoJMP Securities Reiterates Rallybio (RLYB) Market Outperform Recommendation
msn.com - July 26 at 4:29 PM
markets.businessinsider.com logoAnalyst Ratings for Rallybio
markets.businessinsider.com - July 26 at 2:34 AM
marketbeat.com logoDekaBank Deutsche Girozentrale Makes New $168,000 Investment in Rallybio Co. (NASDAQ:RLYB)
marketbeat.com - July 19 at 4:46 AM
nasdaq.com logoRallybio Rings the Closing Bell
nasdaq.com - July 18 at 6:57 PM
finance.yahoo.com logoRallybio Announces Acceptance of Abstract for RLYB116 at the 29th International Complement Workshop (ICW)
finance.yahoo.com - July 11 at 8:21 AM
msn.com logoRallybio (RLYB) Price Target Decreased by 8.96% to 20.74
msn.com - July 6 at 6:05 PM
markets.businessinsider.com logoH.C. Wainwright Sticks to Its Buy Rating for Rallybio (RLYB)
markets.businessinsider.com - June 30 at 8:36 AM
markets.businessinsider.com logoRallybio Says Co-founder Stephen Uden To Replace Martin Mackay As CEO
markets.businessinsider.com - June 29 at 9:24 AM
finance.yahoo.com logoRallybio Announces Succession Plan; Appoints Stephen Uden, M.D., as Chief Executive Officer, Effective August 1, 2023
finance.yahoo.com - June 29 at 9:24 AM
msn.com logoJMP Securities Maintains Rallybio (RLYB) Market Outperform Recommendation
msn.com - June 27 at 9:14 AM
Get Rallybio News Delivered to You Automatically

Sign up to receive the latest news and ratings for RLYB and its competitors with MarketBeat's FREE daily newsletter.



RLYB Media Mentions By Week

RLYB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RLYB
News Sentiment

0.00

0.51

Average
Medical
News Sentiment

RLYB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RLYB Articles
This Week

2

1

RLYB Articles
Average Week

Get Rallybio News Delivered to You Automatically

Sign up to receive the latest news and ratings for RLYB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:RLYB) was last updated on 2/28/2024 by MarketBeat.com Staff